Sales Stay Healthy for Takeda Diabetes Pill

About one month after a Food and Drug Administration advisory panel said the diabetes pill Avandia should remain on the market, but with strict warnings about heart attack risk, a similar pill sold by a Deerfield-based drugmaker is holding its own in the market, according to a new analysis.
Chicago Tribune